Centogene announced that it has received a written notification from Nasdaq, indicating that the company is not in compliance with the minimum Market Value of Publicly Held Shares, or MVPHS, set forth in the Nasdaq Rules for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(3)(C) requires companies to maintain a minimum MVPHS of $15M, and Listing Rule 5810(c)(3)(D) provides that a failure to meet the MVPHS requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the MVPHS of the company for the 30 consecutive business days from July 19 to August 29, the company no longer meets the MVPHS minimum requirement. This notification does not impact the listing and trading of the company’s securities at this time.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CNTG:
- CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
- CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
- CENTOGENE to Participate in Upcoming Conferences in August
- CENTOGENE Regains Compliance With Nasdaq Listing Requirements
- Centogene regains Nasdaq compliance